Effects of liraglutide on diastolic function parameters in patients with type 2 diabetes and coronary artery disease: a randomized crossover study

BACKGROUND: Diastolic dysfunction is highly prevalent in patients with type 2 diabetes mellitus (T2DM) and is associated with overweight, glucose dysregulation and coronary artery disease (CAD). The GLP-1 receptor agonist, liraglutide, has shown to induce weight loss and improve metabolic factors, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumarathurai, Preman, Sajadieh, Ahmad, Anholm, Christian, Kristiansen, Ole P., Haugaard, Steen B., Nielsen, Olav W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791686/
https://www.ncbi.nlm.nih.gov/pubmed/33413428
http://dx.doi.org/10.1186/s12933-020-01205-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791686/
https://www.ncbi.nlm.nih.gov/pubmed/33413428
http://dx.doi.org/10.1186/s12933-020-01205-2

Ejemplares similares